Wilms’ Tumor 1 (WT1): The Vaccine for Cancer
Vaccines have been used to fight and protect against infectious diseases for centuries. With the emergence of immunotherapy in cancer treatment, researchers began investigating vaccines that could be used against cancer, especially against tumors that are resistant to conservative chemotherapy, surg...
Main Authors: | Kyaw Zaw Hein, Shuyang Yao, Siqing Fu |
---|---|
Format: | Article |
Language: | English |
Published: |
Innovative Healthcare Institute
2020-11-01
|
Series: | Journal of Immunotherapy and Precision Oncology |
Subjects: | |
Online Access: | https://jipo.org/doi/pdf/10.36401/JIPO-20-12 |
Similar Items
-
WT1 Trio Peptide-Based Cancer Vaccine for Rare Cancers Expressing Shared Target WT1
by: Yusuke Oji, et al.
Published: (2023-01-01) -
Wilms’ tumor 1 -targeting cancer vaccine: Recent advancements and future perspectives
by: Masahiro Ogasawara
Published: (2024-12-01) -
Antitumor effect of oral cancer vaccine with Bifidobacterium delivering WT1 protein to gut immune system is superior to WT1 peptide vaccine
by: Toshiro Shirakawa, et al.
Published: (2018-01-01) -
Long-term survival of pancreatic cancer patients treated with multimodal therapy combined with WT1-targeted dendritic cell vaccines
by: Shuichi Hanada, et al.
Published: (2019-02-01) -
The Role of Wilms’ Tumor Gene (WT1) Expression as a Marker of Minimal Residual Disease in Acute Myeloid Leukemia
by: Davide Lazzarotto, et al.
Published: (2022-06-01)